, Tracking Stock Market Picks
Enter Symbol:
Parexel International Corporation (PRXL) [hlAlert]

up 246.10 %

Parexel International Corporation (PRXL) rated Overweight with price target $18 by Barclays Capital

Posted on: Tuesday,  Jan 26, 2010  2:25 PM ET by Barclays Capital

Barclays Capital rated Overweight Parexel International Corporation (NASDAQ: PRXL) on 01/26/2010, when the stock price was $20.00. Since
then, Parexel International Corporation has gained 246.10% as of 01/25/2016's recent price of $69.22.
If you would have followed this Barclays Capital's recommendation on PRXL, you would have gained 246.1% of your investment in 2190 days.

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/26/2010 2:25 PM Buy
20.00 18.00
as of 12/31/2010
1 Week down  -5.61 %
1 Month up  18.35 %
3 Months down  -9.94 %
1 YTD up  4.15 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy